Moreover, the treatment strategies for ICI-induced arthritis remain to be established completely and are still controversial.[4] A few case series have suggested that tumor necrosis factor inhibitor (TNFi) is effective for treating ICI-induced arthritis,[5,6] and an interleukin (IL)-6 receptor antagonist is also reported to be effective.[7]. Here, TNF is linked to arthritic joint disease.